Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies
- PMID: 32446652
- PMCID: PMC7235598
- DOI: 10.1016/j.sapharm.2020.05.017
Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies
Abstract
Coronavirus disease 2019 (COVID-19) arising from Wuhan, China, is currently outbreaking worldwide. The World Health Organization (WHO) has declared COVID-19 to be a global pandemic. COVID-19 could cause a wide range of symptoms ranging from self-limiting fever, sore throat, and cough to more severe symptoms that could lead to acute respiratory distress syndrome. As a result of the lockdown and increased demand, drug shortages could become a growing global issue. This article aims to shed light on the potential impact of drug shortages as a result of this pandemic on patient outcomes and the role of pharmacists and pharmacy policymakers in alleviating this emerging problem.
Keywords: COVID-19; Coronavirus; Drug shortage; Pandemic; Pharmacist; Policymaker.
Copyright © 2020. Published by Elsevier Inc.
Conflict of interest statement
Authors have no competing interests to declare.
Similar articles
-
FIP's response to the COVID-19 pandemic: Global pharmacy rises to the challenge.Res Social Adm Pharm. 2021 Jan;17(1):1929-1933. doi: 10.1016/j.sapharm.2020.07.004. Epub 2020 Jul 10. Res Social Adm Pharm. 2021. PMID: 33317767 Free PMC article.
-
Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.Res Social Adm Pharm. 2021 Jan;17(1):1819-1824. doi: 10.1016/j.sapharm.2020.03.012. Epub 2020 Mar 26. Res Social Adm Pharm. 2021. PMID: 32249102 Free PMC article. Review.
-
Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey.Res Social Adm Pharm. 2021 Jan;17(1):1832-1837. doi: 10.1016/j.sapharm.2020.07.006. Epub 2020 Jul 9. Res Social Adm Pharm. 2021. PMID: 33317761 Free PMC article.
-
Medicine shortages in Australia: causes, impact and management strategies in the community setting.Int J Clin Pharm. 2016 Oct;38(5):1133-41. doi: 10.1007/s11096-016-0342-1. Epub 2016 Jul 6. Int J Clin Pharm. 2016. PMID: 27383246
-
Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward.Front Public Health. 2020 Dec 8;8:561924. doi: 10.3389/fpubh.2020.561924. eCollection 2020. Front Public Health. 2020. PMID: 33364224 Free PMC article. Review.
Cited by
-
Hidden Costs of Multiple-Dose Products: Quantifying Ipratropium Inhaler Wastage in the Hospital Setting.Can J Hosp Pharm. 2021 Spring;74(2):117-121. Epub 2021 Apr 1. Can J Hosp Pharm. 2021. PMID: 33896950 Free PMC article.
-
Assessing the Syrian Population's Knowledge, Attitudes, and Practices Regarding Antibiotic Usage.Avicenna J Med. 2021 Aug 13;11(3):132-138. doi: 10.1055/s-0041-1732815. eCollection 2021 Jul. Avicenna J Med. 2021. PMID: 34646789 Free PMC article.
-
Reprise du retard en chirurgie causé par la COVID-19 en Ontario : étude de modélisation de séries chronologiques.CMAJ. 2021 Jan 11;193(2):E63-E73. doi: 10.1503/cmaj.201521-f. CMAJ. 2021. PMID: 33431552 Free PMC article. French.
-
Role of Pharmacists in Antimicrobial Stewardship During COVID-19 Outbreak: A Scoping Review.J Multidiscip Healthc. 2022 Nov 9;15:2605-2614. doi: 10.2147/JMDH.S385170. eCollection 2022. J Multidiscip Healthc. 2022. PMID: 36388623 Free PMC article.
-
HIV Patients' Satisfaction with Pharmaceutical Care at a Nigerian Tertiary Healthcare Facility During the Covid-19 Pandemic.J Int Assoc Provid AIDS Care. 2023 Jan-Dec;22:23259582231159093. doi: 10.1177/23259582231159093. J Int Assoc Provid AIDS Care. 2023. PMID: 36862608 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials